Epilepsy research and treatment
Epilepsy research and treatment is a research topic within Psychiatry and Mental health. Science Explorer counts 62k research works in it since 1950. 15.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, classification, management, and neurobiological aspects of epilepsy and seizures. It covers topics such as antiepileptic drugs, status epilepticus, surgical therapy, inflammation, genetics, and drug resistance in epilepsy.
- Epilepsy
- Seizures
- Classification
- Antiepileptic Drugs
- Status Epilepticus
- Neurobiology
- Surgery
- Inflammation
- Genetics
- Drug Resistance
- Research works
- 62k fractional, since 1950
- In the world top 10%
- 9.8k per year above
- Top-10% rate
- 15.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Epilepsy research and treatment research?
By volume, the United States and China publish the most (2.3k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.3k works
- 2 China 1.1k works
- 3 India 689 works
- 4 United Kingdom 471 works
- 5 Germany 404 works
- 6 Japan 369 works
- 7 Italy 347 works
- 8 Türkiye 304 works
- 9 France 296 works
- 10 Canada 254 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Epilepsy research and treatment research?
By volume in 2022–2025, University College London publishes the most Epilepsy research and treatment research, followed by Capital Medical University and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 University College London United Kingdom 59 works
- 2 Capital Medical University China 43 works
- 3 All India Institute of Medical Sciences India 41 works
- 4 Yale University United States 40 works
- 5 Harvard University United States 39 works
- 6 Massachusetts General Hospital United States 31 works
- 7 Cleveland Clinic United States 31 works
- 8 Inserm France 30 works
- 9 National Hospital for Neurology and Neurosurgery United Kingdom 28 works
- 10 Sichuan University China 27 works
Who are the leading researchers in Epilepsy research and treatment?
The most-cited researchers publishing on Epilepsy research and treatment include M. Dam and Ettore Beghi.
- 1 M. Dam 6.8k citations
- 2 Ettore Beghi 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Epilepsy research and treatment research done?
The largest centres of Epilepsy research and treatment research in 2022–2025 are London (United Kingdom), Beijing (China), Paris (France) and Melbourne (Australia). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre.
Largest cities, 2022–2025
Where it is the local speciality
- Rockville CentreUS · 26.8 works20×
Location quotient: how much more of its research is in Epilepsy research and treatment than the world average.
Where is the best place to study Epilepsy research and treatment?
Among universities, judged by research, Paracelsus Medical University, Magna Graecia University and Goethe University Frankfurt score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Paracelsus Medical University Austria | 68.4 | 32.4% | 20.1× | 9 | +101.5% |
| 2 | Magna Graecia University Italy | 56.7 | 25.1% | 13.0× | 12 | +72.0% |
| 3 | Goethe University Frankfurt Germany | 56.4 | 31.3% | 3.9× | 15 | +239.4% |
| 4 | University College London United Kingdom | 55.7 | 20.2% | 4.6× | 59 | +6.7% |
| 5 | Monash University Australia | 54.2 | 25.7% | 3.0× | 23 | +154.6% |
| 6 | Capital Medical University China | 53.8 | 15.6% | 7.9× | 43 | +38.0% |
| 7 | Harvard University United States | 50.6 | 22.8% | 3.3× | 39 | +42.9% |
| 8 | Karolinska Institutet Sweden | 49.4 | 42.0% | 2.4× | 10 | -5.2% |
| 9 | Thomas Jefferson University United States | 47.7 | 17.8% | 8.0× | 15 | +76.7% |
| 10 | All India Institute of Medical Sciences India | 47.5 | 8.0% | 7.2× | 41 | +80.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Epilepsy research and treatment research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Epilepsy research and treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.